Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

3.7K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.7K
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

4.2K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.2K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

24
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
24
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.2K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding parents' decisions to seek care for children with serious bacterial infections: a qualitative study.

BMJ open·2026
Same author

Response to vaccination and immune status after intrauterine exposure to immunomodulating drugs for maternal IBD.

NPJ vaccines·2026
Same author

Acute Hemorrhagic Edema of Infancy: A Safe Diagnosis or a Diagnostic Challenge? A 15 Year Retrospective Analysis.

Pediatric dermatology·2026
Same author

The Severity and Characteristics of Pediatric Group A Streptococcal Meningitis in the Netherlands (2015-June 2024): Results From a Nationwide Multicenter Cohort Study.

The Pediatric infectious disease journal·2026
Same author

Digital diagnostics, biomarkers and therapeutics in an evolving healthcare system: From promise to practice.

British journal of clinical pharmacology·2026
Same author

Identifying facilitators and barriers to implementing the Feverkidstool, a clinical decision tool, in the emergency department: a qualitative study in the Netherlands.

BMJ open·2026

Related Experiment Video

Updated: Aug 5, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.0K

Optimization of β-Lactam Dosing Regimens in Neonatal Infections: Continuous and Extended Administration versus

Emiel Leegwater1,2,3, Leo Wewerinke4, Anne M de Grauw4

  • 1The Hague Hospital Pharmacy, The Hague, The Netherlands. e.leegwater@hagaziekenhuis.nl.

Clinical Pharmacokinetics
|March 27, 2023
PubMed
Summary

Continuous infusion with a loading dose of beta-lactam antibiotics significantly improves treatment outcomes in neonates compared to intermittent or prolonged methods. This approach enhances drug exposure, leading to higher target attainment rates for infectious diseases.

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

14.8K
Author Spotlight: Characterizing Airway Environments to Advance Model Systems and Antimicrobial Discovery in Cystic Fibrosis and Chronic Respiratory Infections
06:19

Author Spotlight: Characterizing Airway Environments to Advance Model Systems and Antimicrobial Discovery in Cystic Fibrosis and Chronic Respiratory Infections

Published on: October 11, 2024

2.1K

Related Experiment Videos

Last Updated: Aug 5, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.0K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

14.8K
Author Spotlight: Characterizing Airway Environments to Advance Model Systems and Antimicrobial Discovery in Cystic Fibrosis and Chronic Respiratory Infections
06:19

Author Spotlight: Characterizing Airway Environments to Advance Model Systems and Antimicrobial Discovery in Cystic Fibrosis and Chronic Respiratory Infections

Published on: October 11, 2024

2.1K

Area of Science:

  • Pharmacology
  • Neonatal Medicine
  • Infectious Diseases

Background:

  • Beta-lactam antibiotics are standard for neonatal infections, typically given via intermittent infusion.
  • Continuous or prolonged infusion may optimize the time-dependent activity of these antibiotics.
  • This study evaluates different infusion strategies for neonates.

Purpose of the Study:

  • To compare continuous, extended, and intermittent infusion of beta-lactam antibiotics in neonates.
  • To determine the optimal dosing regimen for achieving target drug exposure.
  • To improve treatment efficacy for neonatal infectious diseases.

Main Methods:

  • Population pharmacokinetic models for six beta-lactam antibiotics were used.
  • Monte Carlo simulations involving 30,000 neonates were conducted.
  • Four regimens were simulated: intermittent, prolonged (4h), continuous, and continuous with loading dose.

Main Results:

  • Continuous infusion with a loading dose achieved >90% probability of target attainment for most antibiotics.
  • Penicillin G, amoxicillin, flucloxacillin, cefotaxime, and ceftazidime showed high target attainment with this method.
  • Meropenem may require higher doses, while cefotaxime and ceftazidime doses could potentially be reduced.

Conclusions:

  • Continuous infusion with a loading dose offers superior pharmacokinetic/pharmacodynamic target attainment in neonates.
  • This strategy has the potential to enhance the effectiveness of beta-lactam antibiotic therapy in neonates.
  • Optimized infusion methods are crucial for managing neonatal infections.